Furthermore, OPN can also recruit myeloid-derived suppressor cells and other bone marrow-derived cells to the tumor microenvironment and metastatic niches, thereby suppressing anticancer immunity and promoting metastasis [76–78]. The gene discussed is SPP1; the disease is neoplasm.